Blythefan, According to ASX releases and my DD:
the company won't require any more cash until it is cash flow positive. Also the plant processes are tried and tested the technical aspects are not a problem.
The company does, just like any other, have execution risk. The mangament is has pretty good experience is REE some having worked in the industry in China.
- Forums
- ASX - By Stock
- LYC
- gone a bit quiet
gone a bit quiet, page-13
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add LYC (ASX) to my watchlist
(20min delay)
|
|||||
Last
$7.62 |
Change
-0.130(1.68%) |
Mkt cap ! $7.113B |
Open | High | Low | Value | Volume |
$7.64 | $7.69 | $7.59 | $9.039M | 1.183M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
32 | 19849 | $7.61 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$7.62 | 1719 | 12 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
25 | 9572 | 7.610 |
15 | 15857 | 7.600 |
17 | 18848 | 7.590 |
12 | 22759 | 7.580 |
6 | 11209 | 7.570 |
Price($) | Vol. | No. |
---|---|---|
7.620 | 2158 | 9 |
7.630 | 18259 | 25 |
7.640 | 5267 | 11 |
7.650 | 11383 | 12 |
7.660 | 14570 | 11 |
Last trade - 14.35pm 13/11/2024 (20 minute delay) ? |
Featured News
LYC (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online